This inventor holds 3 USPTO granted patents. Top assignee: Idexx Laboratories, Inc.. Active years: 2003-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2007
Title: Innovations by Hongliang Guo in Canine Therapeutics
Introduction
Hongliang Guo is a notable inventor based in Scarborough, ME (US). He has made significant contributions to the field of veterinary medicine, particularly in the development of therapeutics for canines. With a total of 3 patents, his work focuses on innovative methods and compositions that enhance the treatment of canine allergies and other health issues.
Latest Patents
One of his latest patents is titled "Methods for using canine immunoglobulin variable domains and caninized antibodies." This invention provides canine heavy chain and light chain variable domain nucleic acids and polypeptides. It also includes caninized antibodies that are useful in treating canine allergies. The general process of caninization allows for the development of therapeutics that can address various conditions, including allergies, osteosarcoma, and lymphoma.
Another significant patent is "Methods and compositions concerning canine interleukin 5." This invention outlines the nucleotide and amino acid sequences of canine IL-5, along with a recombinant DNA molecule that comprises the DNA sequence of canine IL-5. It also discusses methods for producing polypeptides and antibodies that bind to canine IL-5, which can be crucial for developing effective treatments.
Career Highlights
Hongliang Guo is currently employed at IDEXX Laboratories, Inc., where he continues to innovate in the field of veterinary therapeutics. His work has been instrumental in advancing the understanding and treatment of canine health issues.
Collaborations
He has collaborated with notable coworkers, including Robert L. Lawton and Ashok P. Aiyappa, contributing to a dynamic research environment that fosters innovation.
Conclusion
Hongliang Guo's contributions to canine therapeutics through his patents and work at IDEXX Laboratories, Inc. highlight his commitment to improving the health and well-being of dogs. His innovative approaches are paving the way for new treatments in veterinary medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile